Literature DB >> 25469305

Vascular invasion affects survival in early hepatocellular carcinoma.

Chen-Hsi Hsieh1, Chang-Kuo Wei2, Wen-Yao Yin2, Chun-Ming Chang2, Shiang-Jiun Tsai3, Li-Ying Wang4, Wen-Yen Chiou3, Moon-Sing Lee5, Hon-Yi Lin6, Shih-Kai Hung5.   

Abstract

Hepatocellular carcinoma (HCC) is an aggressive malignant tumor with a high mortality rate. The optimal therapeutic choice for early HCC is surgical resection. However, the rate of intrahepatic recurrence is high. The objective of this study was to evaluate the effect of various factors on the survival of patients with early HCC. Between January 1st, 2006 and December 31st, 2013, a total of 89 patients who underwent surgery for HCC were retrospectively enrolled. The analysis was conducted using the Student's t-test, Chi-square test, Kaplan-Meier method and Cox proportional hazard regression model to assess potential confounding and predictive variables. The 3-year overall survival (OS) rate was 71%. The 3-year OS rates in patients with and those without vascular invasion were 62.1 and 92.8%, respectively (P<0.003). Based on the multivariate analysis, postoperative pathological vascular invasion (hazard ratio = 4.96; 95% confidence interval: 1.55-15.9) remained an independent predictor of adverse long-term outcome. Furthermore, vascular invasion was significantly associated with intrahepatic metastasis. These data emphasize the need for effective adjuvant therapy in selected high-risk patients with early HCC. Further studies are required to determine the optimal approach to further improving the prognosis of early HCC.

Entities:  

Keywords:  hepatocellular carcinoma; surgery; vascular invasion

Year:  2014        PMID: 25469305      PMCID: PMC4251122          DOI: 10.3892/mco.2014.420

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  22 in total

1.  Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.

Authors:  Zhi-Yong Huang; Bin-Yong Liang; Min Xiong; Da-Qian Zhan; Shuang Wei; Guo-Ping Wang; Yi-Fa Chen; Xiao-Ping Chen
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

Review 2.  Liver transplantation and conventional surgery for advanced hepatocellular carcinoma.

Authors:  Shin Hwang; Deok-Bog Moon; Sung-Gyu Lee
Journal:  Transpl Int       Date:  2010-05-05       Impact factor: 3.782

3.  Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.

Authors:  Wen-Yen Huang; Yee-Min Jen; Meei-Shyuan Lee; Li-Ping Chang; Chang-Ming Chen; Kai-Hsiung Ko; Kuen-Tze Lin; Jang-Chun Lin; Hsing-Lung Chao; Chun-Shu Lin; Yu-Fu Su; Chao-Yueh Fan; Yao-Wen Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-17       Impact factor: 7.038

4.  The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.

Authors:  Shuji Sumie; Osamu Nakashima; Koji Okuda; Ryoko Kuromatsu; Atsushi Kawaguchi; Masahito Nakano; Manabu Satani; Shingo Yamada; Shusuke Okamura; Maisa Hori; Tatsuyuki Kakuma; Takuji Torimura; Michio Sata
Journal:  Ann Surg Oncol       Date:  2013-11-20       Impact factor: 5.344

5.  Recurrence of hepatocellular carcinoma after surgery.

Authors:  J Yamamoto; T Kosuge; T Takayama; K Shimada; S Yamasaki; H Ozaki; N Yamaguchi; M Makuuchi
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

6.  Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma.

Authors:  N Nagasue; M Uchida; Y Makino; Y Takemoto; A Yamanoi; T Hayashi; Y C Chang; H Kohno; T Nakamura; H Yukaya
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

7.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

8.  Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma.

Authors:  K S Chok; K K Ng; R T Poon; C M Lo; S T Fan
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

9.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Authors:  Charles Cha; Yuman Fong; William R Jarnagin; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

10.  Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Authors:  Shimul A Shah; Sean P Cleary; Alice C Wei; Ilun Yang; Bryce R Taylor; Alan W Hemming; Bernard Langer; David R Grant; Paul D Greig; Steven Gallinger
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

View more
  17 in total

1.  Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?

Authors:  Chuan Chen; Dong-Ping Chen; Yan-Yan Gu; Liang-Hao Hu; Dan Wang; Jin-Huan Lin; Zhao-Shen Li; Jing Xu; Ge Wang
Journal:  Tumour Biol       Date:  2015-04-02

2.  A Novel Angiogenesis-Related Prognostic Signature Associated with the Hepatocellular Carcinoma Immune Microenvironment and Survival Outcome.

Authors:  Xin Jiang; Yushuang Xu; Di Chen; Mengmeng Wang; Mengjun Qiu; Lina Xiong; Li Zhang; Honglu Yu; Zhifan Xiong
Journal:  Int J Gen Med       Date:  2022-01-07

3.  LI-RADS Classification and Outcomes of Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.

Authors:  Yuji Tachibana; Ryo Takaji; Miyuki Maruno; Koichi Honda; Mizuki Endo; Kazunari Murakami; Yoshiki Asayama
Journal:  Cancer Diagn Progn       Date:  2022-07-03

4.  Pien Tze Huang Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells by Repressing PDGFRB/YAP/CCN2 Axis Activity.

Authors:  Zhi-Yi Luo; Qi Tian; Niang-Mei Cheng; Wen-Han Liu; Ye Yang; Wei Chen; Xiang-Zhi Zhang; Xiao-Yuan Zheng; Ming-Sheng Chen; Qiu-Yu Zhuang; Bi-Xing Zhao; Cong-Sheng Liu; Xiao-Long Liu; Qin Li; Ying-Chao Wang
Journal:  Chin J Integr Med       Date:  2022-08-10       Impact factor: 2.626

5.  Outcomes of Geriatric Patients with Hepatocellular Carcinoma.

Authors:  Chern-Horng Lee; Tzung-Hai Yen; Sen-Yung Hsieh
Journal:  Curr Oncol       Date:  2022-06-16       Impact factor: 3.109

6.  Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death.

Authors:  Kashif Rafiq Zahid; Shiming Han; Fuling Zhou; Umar Raza
Journal:  Cell Oncol (Dordr)       Date:  2018-09-20       Impact factor: 7.051

7.  Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.

Authors:  Bao-Jiang Liu; Song Gao; Xu Zhu; Jian-Hai Guo; Fu-Xin Kou; Shao-Xing Liu; Xin Zhang; Xiao-Dong Wang; Guang Cao; Hui Chen; Peng Liu; Lin-Zhong Zhu; Hai-Feng Xu; Ren-Jie Yang
Journal:  Biomed Res Int       Date:  2021-07-14       Impact factor: 3.411

8.  Construction of a ceRNA Network and a Prognostic lncRNA Signature associated with Vascular Invasion in Hepatocellular Carcinoma based on Weighted Gene Co-Expression Network Analysis.

Authors:  Haisu Tao; Jiang Li; Junjie Liu; Tong Yuan; Erlei Zhang; Huifang Liang; Zhiyong Huang
Journal:  J Cancer       Date:  2021-05-05       Impact factor: 4.207

9.  Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.

Authors:  Maya S Krishnan; Anand Rajan Kd; Jangho Park; Vinodhini Arjunan; Fernando Jose Garcia Marques; Abel Bermudez; Olivia A Girvan; Nam S Hoang; Jun Yin; Mindie H Nguyen; Nishita Kothary; Sharon Pitteri; Dean W Felsher; Renumathy Dhanasekaran
Journal:  Hepatology       Date:  2021-05-08       Impact factor: 17.298

10.  Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion.

Authors:  Hui Zhao; Ye Hua; Zhihua Lu; Shen Gu; Laifa Zhu; Yuan Ji; Yudong Qiu; Tu Dai; Huihan Jin
Journal:  Oncotarget       Date:  2017-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.